PROMISING MF TREATMENT, MOMELOTINIB, IN DEVELOPMENT ONCE MORE
April 12, 2019 After completing a number of clinical trials, The MPN community was disappointed when a promising compound in development for myelofibrosis, momelotinib, was… Read More »PROMISING MF TREATMENT, MOMELOTINIB, IN DEVELOPMENT ONCE MORE